$99.18
0.910.93%
At close: Dec 17, 4:00 PM EST
$99.16
-0.0213-0.02%
After Hours: 7:21 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
The dividend Ex-Date was 2 days ago
Merck & Co Insider Trading Activity | NYSE:MRK | Benzinga
Track the latest Merck & Co insider trading activity. Stay informed on recent buys, sells, and market impact for Merck & Co stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Merck & Co Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On November 12, 2025, Cristal N Downing, the company's CHIEF COMM. & PUBLIC AFRS OFCR sold 7.09K shares for $87 each.
- On November 4, 2025, David Michael Williams, the company's EVP,CHIEF INFO&DIGITAL OFFICER sold 8.61K shares for $83.59 each.
Ownership Statistics for Merck & Co Inc
Shares Outstanding
2.482B
Insider Shares Owned
4.164M
Insider Percentage Owned
0.17%
Institutional Shares Held
1.279B
Institutional Percentage Held
51.5%
| Nov 12, 2025 | Cristal N Downing | CHIEF COMM. & PUBLIC AFRS OFCR | -7.08K | $87.00 | -$616.39K | SELL | -100.00% | 0.00 | Nov 10 | View |
| Nov 04, 2025 | David Michael Williams | EVP,CHIEF INFO&DIGITAL OFFICER | -8.61K | $83.59 | -$720.04K | SELL | -25.95% | 24.58K | Nov 03 | View |
| Apr 29, 2025 | Dalton Smart | SVP FIN. - GLOBAL CONTROLLER | 738.00 | $70.42 | -$62.32K | SELL-OPTIONS | 10.48% | 7.78K | Apr 25 | View |
| Feb 20, 2025 | Johannes Oosthuizen | PRESIDENT, U.S. MARKET | -8.50K | $84.09 | -$714.74K | SELL | -21.68% | 30.71K | Feb 19 | View |
| Feb 13, 2025 | David Michael Williams | EVP,CHIEF INFO&DIGITAL OFFICER | -6.00K | $85.34 | -$512.06K | SELL | -19.92% | 24.12K | Feb 13 | View |
| Feb 07, 2025 | Inge G Thulin | DIRECTOR | 2.83K | $88.25 | $250.00K | BUY | 2832.86% | 2.93K | Feb 06 | View |
| Feb 07, 2025 | Cristal N Downing | CHIEF COMM. & PUBLIC AFRS OFCR | -2.36K | $88.76 | -$209.55K | SELL | -24.99% | 7.08K | Feb 06 | View |
| Feb 07, 2025 | Douglas M. Baker Jr. | DIRECTOR | 15.00K | $88.50 | $1.33M | BUY | 1500.00% | 16.00K | Feb 05 | View |
| Feb 15, 2024 | Caroline Litchfield | EVP & CFO | 0.00 | $91.79 | -$2.58M | SELL-OPTIONS | 0.00% | 50.91K | Feb 14 | View |
| Feb 15, 2024 | Robert M Davis | CHAIRMAN, CEO & PRESIDENT | 0.00 | $99.85 | -$12.14M | SELL-OPTIONS | 0.00% | 348.33K | Feb 13 - Feb 14 | View |
| Feb 14, 2024 | Joseph Romanelli | PRESIDENT, HUMAN HEALTH INT?L | -1.00K | $124.89 | -$124.89K | SELL | -4.86% | 19.57K | Feb 13 | View |
| Feb 12, 2024 | Dean Y Li | EXECUTIVE VP & PRESIDENT, MRL | 0.00 | $93.78 | -$932.53K | SELL-OPTIONS | 0.00% | 46.24K | Feb 09 | View |
| Feb 08, 2024 | David Michael Williams | EVP,CHIEF INFO&DIGITAL OFFICER | -1.45K | $127.57 | -$185.11K | SELL | -6.82% | 19.81K | Feb 07 | View |
| Feb 05, 2024 | Johannes Oosthuizen | PRESIDENT, U.S. MARKET | 1.98K | $102.99 | -$761.20K | SELL-OPTIONS | 9.26% | 23.33K | Feb 02 | View |
| Feb 02, 2024 | Steven Mizell | EVP, CHIEF HR OFFICER | -17.70K | $100.15 | -$3.99M | SELL | -42.84% | 23.62K | Feb 02 | View |
| Feb 02, 2024 | Jennifer Zachary | EVP, GENERAL COUNSEL | -30.08K | $107.03 | -$4.59M | SELL | -50.87% | 29.06K | Feb 02 | View |
| Nov 13, 2023 | Johannes Oosthuizen | PRESIDENT, U.S. MARKET | -2.08K | $102.38 | -$213.06K | SELL | -10.27% | 18.19K | Nov 09 | View |
| Nov 09, 2023 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALLTH | -43.82K | $105.03 | -$4.60M | SELL | -27.95% | 112.99K | Nov 08 | View |
| Aug 15, 2023 | Steven Mizell | EVP, CHIEF HR OFFICER | -4.25K | $109.01 | -$463.29K | SELL | -15.63% | 22.94K | Aug 14 | View |
| Aug 04, 2023 | Steven Mizell | EVP, CHIEF HR OFFICER | -4.50K | $105.49 | -$474.70K | SELL | -14.20% | 27.19K | Aug 03 | View |
| Aug 03, 2023 | Joseph Romanelli | PRESIDENT, HUMAN HEALTH INT?L | -89.00 | $107.37 | -$9.56K | SELL | -100.00% | 0.00 | Aug 02 | View |
| Jun 30, 2023 | Joseph Romanelli | PRESIDENT, HUMAN HEALTH INT?L | 374.00 | $106.53 | $40.67K | BUY | 1.85% | 20.60K | Dec 02 - Apr 26 | View |
| May 05, 2023 | Steven Mizell | EVP, CHIEF HR OFFICER | -1.40K | $97.28 | -$2.43M | SELL | -4.23% | 31.69K | May 03 | View |
| May 05, 2023 | Jennifer Zachary | EVP, GENERAL COUNSEL | -19.14K | $117.59 | -$2.25M | SELL | -35.27% | 35.13K | May 04 | View |
| May 05, 2023 | Rita Karachun | SR. VP FINCE-GLOBAL CONTROLLER | 1.15K | $92.59 | -$744.70K | SELL-OPTIONS | 2.58% | 45.71K | May 03 - May 04 | View |
| May 03, 2023 | David Michael Williams | EVP,CHIEF INFO&DIGITAL OFFICER | -1.09K | $89.01 | -$495.26K | SELL | -9.01% | 11.06K | May 01 - May 02 | View |
| May 02, 2023 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $87.20 | -$8.03M | SELL-OPTIONS | 0.00% | 155.70K | Apr 28 - May 01 | View |
| Apr 28, 2023 | Robert M Davis | CHAIRMAN, CEO & PRESIDENT | 0.00 | $85.49 | -$8.44M | SELL-OPTIONS | 0.00% | 271.82K | Apr 28 | View |
| Apr 14, 2023 | Sanat Chattopadhyay | EXE V-P & PRES. MMD | 0.00 | $87.04 | -$7.51M | SELL-OPTIONS | 0.00% | 46.99K | Apr 13 | View |
| Feb 16, 2023 | Joseph Romanelli | PRESIDENT, HUMAN HEALTH INT?L | -5.00K | $108.22 | -$541.10K | SELL | -19.78% | 20.28K | Feb 15 | View |
| Feb 14, 2023 | Steven Mizell | EVP, CHIEF HR OFFICER | -1.81K | $109.10 | -$198.02K | SELL | -5.20% | 33.09K | Feb 13 | View |
| Feb 10, 2023 | Steven Mizell | EVP, CHIEF HR OFFICER | -5.00K | $107.00 | -$535.01K | SELL | -12.53% | 34.90K | Feb 09 | View |
| Feb 08, 2023 | Steven Mizell | EVP, CHIEF HR OFFICER | -4.44K | $104.25 | -$462.47K | SELL | -10.01% | 39.90K | Feb 06 | View |
| Feb 06, 2023 | Jennifer Zachary | EVP, GENERAL COUNSEL | 0.00 | $79.61 | -$3.56M | SELL-OPTIONS | 0.00% | 53.92K | Feb 03 | View |
| Jan 11, 2023 | Sanat Chattopadhyay | EXE V-P & PRES. MMD | 0.00 | $82.68 | -$4.98M | SELL-OPTIONS | 0.00% | 75.11K | Jan 09 | View |
| Nov 10, 2022 | Steven Mizell | EVP, CHIEF HR OFFICER | 0.00 | $101.18 | -$3.54M | SELL-OPTIONS | 0.00% | 32.14K | Nov 08 - Nov 10 | View |
| Nov 10, 2022 | Johannes Oosthuizen | PRESIDENT, U.S. MARKET | -1.79K | $103.21 | -$185.26K | SELL | -9.69% | 16.73K | Nov 09 | View |
| Nov 10, 2022 | Robert M Davis | CEO & PRESIDENT | 0.00 | $102.44 | -$17.17M | SELL-OPTIONS | 0.00% | 247.59K | Nov 09 | View |
| Nov 08, 2022 | Kenneth C Frazier | EXECUTIVE CHAIR | 0.00 | $99.55 | -$23.47M | SELL-OPTIONS | 0.00% | 705.13K | Nov 07 | View |
| Nov 07, 2022 | Johannes Oosthuizen | PRESIDENT, U.S. MARKET | 7.18K | $99.47 | -$4.53M | SELL-OPTIONS | 63.31% | 18.53K | Nov 07 | View |
| Nov 07, 2022 | Kenneth C Frazier | EXECUTIVE CHAIR | 0.00 | $98.66 | -$46.37M | SELL-OPTIONS | 0.00% | 705.13K | Nov 03 - Nov 04 | View |
| Nov 03, 2022 | Kenneth C Frazier | EXECUTIVE CHAIR | -5.63K | $99.86 | -$59.91M | SELL | -0.79% | 705.13K | Nov 01 - Nov 02 | View |
| Nov 01, 2022 | Sanat Chattopadhyay | EXE V-P & PRES. MMD | 0.00 | $100.10 | -$10.04M | SELL-OPTIONS | 0.00% | 112.98K | Oct 28 | View |
| Nov 01, 2022 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $100.26 | -$16.50M | SELL-OPTIONS | 0.00% | 138.17K | Oct 28 | View |
| Nov 01, 2022 | Kenneth C Frazier | EXECUTIVE CHAIR | 0.00 | $100.44 | -$87.09M | SELL-OPTIONS | 0.00% | 710.76K | Oct 28 - Oct 31 | View |
| Nov 01, 2022 | Rita Karachun | SR. VP FINCE-GLOBAL CONTROLLER | 0.00 | $100.34 | -$3.21M | SELL-OPTIONS | 0.00% | 41.10K | Oct 28 | View |
| Nov 01, 2022 | Steven Mizell | EVP, CHIEF HR OFFICER | -8.00K | $99.63 | -$2.49M | SELL | -19.93% | 32.14K | Oct 28 | View |
| Nov 01, 2022 | Johannes Oosthuizen | PRESIDENT, U.S. MARKET | -3.17K | $100.52 | -$317.41K | SELL | -21.84% | 11.34K | Oct 28 - Oct 30 | View |
| Nov 01, 2022 | Jennifer Zachary | EVP, GENERAL COUNSEL | -16.61K | $99.38 | -$16.42M | SELL | -30.39% | 38.04K | Oct 28 | View |
| Nov 10, 2021 | Kenneth C Frazier | EXECUTIVE CHAIR | 0.00 | $82.26 | -$54.61M | SELL-OPTIONS | 0.00% | 591.14K | Nov 09 | View |
| Nov 05, 2021 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $90.40 | -$2.69M | SELL-OPTIONS | 0.00% | 118.09K | Nov 04 | View |
| Nov 05, 2021 | Caroline Litchfield | EVP & CFO | 4.35K | $91.00 | -$1.67M | SELL-OPTIONS | 22.00% | 24.11K | Nov 04 | View |
| Nov 04, 2021 | Rita Karachun | SR. VP FINCE-GLOBAL CONTROLLER | 0.00 | $88.45 | -$2.21M | SELL-OPTIONS | 0.00% | 35.80K | Nov 03 | View |
| Nov 03, 2021 | Julie L Gerberding | EVP, CHIEF PATIENT OFFICER | 0.00 | $87.91 | -$8.46M | SELL-OPTIONS | 0.00% | 39.16K | Nov 01 | View |
| Nov 02, 2021 | Frank Clyburn | EVP & PRES ? HUMAN HEALTH | 1.20K | $87.96 | -$3.39M | SELL-OPTIONS | 1.22% | 98.88K | Oct 30 - Nov 01 | View |
| Nov 02, 2021 | Sanat Chattopadhyay | EXE V-P & PRES. MMD | 0.00 | $87.32 | -$2.15M | SELL-OPTIONS | 0.00% | 93.15K | Oct 29 | View |
| Nov 02, 2021 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $87.56 | -$11.86M | SELL-OPTIONS | 0.00% | 118.09K | Oct 29 | View |
| May 11, 2021 | Frank Clyburn | EVP & PRES ? HUMAN HEALTH | 0.00 | $78.32 | -$1.51M | SELL-OPTIONS | 0.00% | 96.10K | May 10 | View |
| Nov 12, 2020 | Kenneth C Frazier | — | -280.00K | $81.42 | -$22.80M | SELL | -40.24% | 415.75K | Nov 09 | View |
| Oct 06, 2020 | Robert M Davis | — | 0.00 | $81.03 | -$20.36M | OPTION EXERCISE | 0.00% | 171.06K | Oct 05 | View |
| Aug 17, 2020 | Sanat Chattopadhyay | — | -10.38K | $83.01 | -$861.68K | SELL | -13.35% | 67.37K | Aug 13 | View |
| Aug 06, 2020 | Frank Clyburn | — | 0.00 | $81.55 | -$1.54M | OPTION EXERCISE | 0.00% | 82.39K | Aug 05 | View |
| Jul 20, 2020 | Julie L Gerberding | — | -18.17K | $80.00 | -$2.90M | OPTION EXERCISE | -40.61% | 26.58K | Jul 17 | View |
| May 07, 2020 | Wendell P Weeks | — | 0.00 | $76.02 | -$380.10K | OPTION EXERCISE | 0.00% | 100.00 | May 07 | View |
| May 07, 2020 | Leslie A Brun | — | 0.00 | $75.46 | -$377.30K | OPTION EXERCISE | 0.00% | 1.95K | May 07 | View |
| Jan 15, 2020 | Julie L Gerberding | — | -19.52K | $89.34 | -$9.12M | OPTION EXERCISE | -34.52% | 37.04K | Jan 13 | View |
| Aug 12, 2019 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $85.02 | -$3.24M | SELL-OPTIONS | 0.00% | 72.60K | Aug 08 - Aug 09 | View |
| Jun 27, 2019 | Robert M Davis | EVP, GLOBAL SVCS & CFO | 0.00 | $85.43 | -$18.51M | SELL-OPTIONS | 0.00% | 137.66K | Jun 25 | View |
| May 09, 2019 | Frank Clyburn | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $58.51 | -$960.93K | SELL-OPTIONS | 0.00% | 69.10K | May 07 | View |
| May 07, 2019 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALLTH | 0.00 | $59.64 | -$1.42M | SELL-OPTIONS | 0.00% | 72.14K | May 03 | View |
| Mar 27, 2019 | Robert M Davis | EVP, GLOBAL SVCS & CFO | 0.00 | $70.30 | -$4.65M | SELL-OPTIONS | 0.00% | 137.66K | Mar 25 | View |
| Mar 20, 2019 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $60.67 | -$8.24M | SELL-OPTIONS | 0.00% | 801.73K | Mar 20 | View |
| Mar 14, 2019 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $60.65 | -$799.75K | SELL-OPTIONS | 0.00% | 801.73K | Mar 13 | View |
| Mar 06, 2019 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $60.65 | -$858.76K | SELL-OPTIONS | 0.00% | 801.73K | Mar 04 - Mar 05 | View |
| Feb 22, 2019 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $59.65 | -$3.91M | SELL-OPTIONS | 0.00% | 695.96K | Feb 21 - Feb 22 | View |
| Feb 19, 2019 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $59.66 | -$5.52M | SELL-OPTIONS | 0.00% | 695.96K | Feb 15 - Feb 19 | View |
| Feb 14, 2019 | Sanat Chattopadhyay | EXE V-P & PRES. MMD | 0.00 | $58.40 | -$2.98M | SELL-OPTIONS | 0.00% | 51.47K | Feb 12 | View |
| Feb 14, 2019 | Wendell P Weeks | DIRECTOR | 0.00 | $51.50 | -$272.05K | SELL-OPTIONS | 0.00% | 100.00 | Feb 13 | View |
| Feb 14, 2019 | Rita A Karachun | SR. VP FINCE-GLOBAL CONTROLLER | 0.00 | $69.06 | -$1.28M | SELL-OPTIONS | 0.00% | 16.17K | Feb 14 | View |
| Feb 11, 2019 | Leslie A Brun | DIRECTOR | 1.95K | $50.76 | -$114.18K | SELL-OPTIONS | ∞ | 1.95K | Feb 08 | View |
| Feb 06, 2019 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $58.68 | -$8.98M | SELL-OPTIONS | 0.00% | 695.96K | Feb 05 | View |
| Feb 04, 2019 | Thomas H Glocer | DIRECTOR | 0.00 | $52.85 | -$462.14K | SELL-OPTIONS | 0.00% | 5.10K | Feb 04 | View |
| Nov 08, 2018 | Julie L Gerberding | EVP STRAT COMM, GL PUB POLICY | 0.00 | $64.91 | -$740.95K | SELL-OPTIONS | 0.00% | 46.26K | Nov 07 | View |
| Nov 08, 2018 | Roger M Perlmutter | EXE V-P & PRES, MRL | 0.00 | $60.12 | -$6.83M | SELL-OPTIONS | 0.00% | 141.55K | Nov 08 | View |
| Nov 02, 2018 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | 0.00 | $56.55 | -$9.59M | SELL-OPTIONS | 0.00% | 55.41K | Nov 01 | View |
| Nov 01, 2018 | Richard R DeLuca | EVP&PRES, MERCK ANIMAL HEALTH | 0.00 | $53.10 | -$963.02K | SELL-OPTIONS | 0.00% | 57.73K | Oct 30 | View |
| Nov 01, 2018 | Ashley Watson | SVP CHIEF ETHICS & COM OFFICER | 0.00 | $66.35 | -$750.94K | SELL-OPTIONS | 0.00% | 9.96K | Oct 31 | View |
| Oct 03, 2018 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $54.31 | -$9.94M | SELL-OPTIONS | 0.00% | 695.91K | Oct 02 | View |
| Sep 19, 2018 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $53.32 | -$9.38M | SELL-OPTIONS | 0.00% | 695.91K | Sep 18 | View |
| Sep 18, 2018 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -7.36K | $53.37 | -$3.88M | SELL | -11.73% | 55.41K | Sep 17 | View |
| Aug 06, 2018 | Sanat Chattopadhyay | EXE V-P & PRES. MMD | 0.00 | $50.03 | -$886.19K | SELL-OPTIONS | 0.00% | 51.47K | Aug 03 | View |
| Aug 02, 2018 | Rita A Karachun | SR. VP FINCE-GLOBAL CONTROLLER | -5.00K | $65.01 | -$325.04K | SELL | -23.61% | 16.17K | Aug 02 | View |
| Aug 01, 2018 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | -18.75K | $49.25 | -$7.19M | SELL | -2.62% | 695.91K | Jul 31 | View |
| Jun 19, 2018 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -34.09K | $48.78 | -$4.52M | SELL | -35.20% | 62.77K | Jun 18 | View |
| May 16, 2018 | Julie L Gerberding | EVP STRAT COMM, GL PUB POLICY | -9.97K | $59.66 | -$594.96K | SELL | -17.91% | 45.72K | May 15 | View |
| Apr 17, 2018 | Mirian M. Graddick-Weir | EXE V-P, HR | -24.00K | $58.00 | -$1.39M | SELL | -22.98% | 80.43K | Apr 16 | View |
| Feb 09, 2018 | Wendell P Weeks | DIRECTOR | 0.00 | $45.80 | -$77.63K | SELL-OPTIONS | 0.00% | 100.00 | Feb 09 | View |
| Jan 16, 2018 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -50.61K | $49.09 | -$4.40M | SELL | -44.64% | 62.77K | Jan 16 | View |
| Jan 16, 2018 | Michael J Holston | EVP, GENERAL COUNSEL | -12.50K | $61.63 | -$770.38K | SELL | -20.29% | 49.09K | Jan 16 | View |
| Jan 16, 2018 | Mirian M. Graddick-Weir | EXE V-P, HR | -13.00K | $52.83 | -$1.68M | SELL | -12.21% | 93.48K | Jan 12 - Jan 16 | View |
| Nov 09, 2017 | Thomas H Glocer | DIRECTOR | 0.00 | $47.12 | -$90.78K | SELL-OPTIONS | 0.00% | 5.10K | Nov 08 | View |
| May 12, 2017 | C. Robert Kidder | DIRECTOR | 0.00 | $49.36 | -$141.75K | SELL-OPTIONS | 0.00% | 10.34K | May 12 | View |
| Apr 04, 2017 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -53.85K | $63.48 | -$3.42M | SELL | -31.64% | 116.34K | Apr 03 | View |
| Feb 15, 2017 | Rita A Karachun | SR. VP FINCE-GLOBAL CONTROLLER | -2.95K | $64.73 | -$191.23K | SELL | -20.19% | 11.67K | Feb 14 | View |
| Feb 09, 2017 | Patricia F Russo | DIRECTOR | 0.00 | $49.81 | -$146.17K | SELL-OPTIONS | 0.00% | 13.15K | Feb 08 | View |
| Feb 06, 2017 | Peter C Wendell | DIRECTOR | 0.00 | $48.10 | -$467.76K | SELL-OPTIONS | 0.00% | 1.00K | Feb 03 | View |
| Feb 06, 2017 | Michael J Holston | EVP, GENERAL COUNSEL | -14.00K | $61.52 | -$1.27M | SELL | -21.78% | 50.28K | Feb 03 | View |
| Feb 06, 2017 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | 0.00 | $49.04 | -$1.07M | SELL-OPTIONS | 0.00% | 130.22K | Feb 03 | View |
| Feb 06, 2017 | Thomas R Cech | DIRECTOR | 0.00 | $49.30 | -$141.15K | SELL-OPTIONS | 0.00% | 100.00 | Feb 03 | View |
| Feb 06, 2017 | Wendell P Weeks | DIRECTOR | 0.00 | $58.18 | -$63.24K | SELL-OPTIONS | 0.00% | 100.00 | Feb 06 | View |
| Jan 17, 2017 | Wendell P Weeks | DIRECTOR | -100.00 | $31.35 | -$3.13K | SELL | -50.00% | 100.00 | Oct 04 | View |
| Nov 10, 2016 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $44.24 | -$5.82M | SELL-OPTIONS | 0.00% | 512.63K | Nov 09 - Nov 10 | View |
| Nov 08, 2016 | Julie L Gerberding | EVP STRAT COMM, GL PUB POLICY | 0.00 | $50.78 | -$1.58M | SELL-OPTIONS | 0.00% | 39.12K | Nov 07 | View |
| Nov 02, 2016 | Rochelle B Lazarus | DIRECTOR | 0.00 | $48.20 | -$434.25K | SELL-OPTIONS | 0.00% | 6.35K | Nov 02 | View |
| Nov 02, 2016 | Peter C Wendell | DIRECTOR | 0.00 | $55.68 | -$38.20K | SELL-OPTIONS | 0.00% | 1.00K | Nov 02 | View |
| Oct 04, 2016 | Mirian M. Graddick-Weir | EXE V-P, HR | 0.00 | $53.13 | -$729.63K | SELL-OPTIONS | 0.00% | 88.17K | Oct 03 | View |
| Sep 01, 2016 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | 0.00 | $48.05 | -$1.14M | SELL-OPTIONS | 0.00% | 130.22K | Sep 01 | View |
| Aug 10, 2016 | Clark Golestani | EVP & CHIEF INFO OFFICER | -3.00K | $63.03 | -$189.09K | SELL | -13.08% | 19.94K | Aug 10 | View |
| Aug 05, 2016 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $49.33 | -$9.78M | SELL-OPTIONS | 0.00% | 512.60K | Aug 05 | View |
| Jul 05, 2016 | Mirian M. Graddick-Weir | EXE V-P, HR | -45.00K | $57.99 | -$2.61M | SELL | -34.05% | 87.15K | Jul 05 | View |
| Jul 05, 2016 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $54.51 | -$418.80K | SELL-OPTIONS | 0.00% | 526.18K | Jul 01 - Jul 05 | View |
| Jul 01, 2016 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | 0.00 | $50.99 | -$669.41K | SELL-OPTIONS | 0.00% | 130.22K | Jul 01 | View |
| Jul 01, 2016 | Mirian M. Graddick-Weir | EXE V-P, HR | 0.00 | $49.09 | -$503.55K | SELL-OPTIONS | 0.00% | 132.15K | Jul 01 | View |
| May 20, 2016 | Clark Golestani | EVP & CHIEF INFO OFFICER | -1.23K | $49.89 | -$446.61K | SELL | -4.45% | 26.43K | May 19 - May 20 | View |
| May 12, 2016 | Michael J Holston | EVP, GENERAL COUNSEL | 0.00 | $49.54 | -$992.16K | SELL-OPTIONS | 0.00% | 64.28K | May 10 | View |
| Apr 14, 2016 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $50.15 | -$1.56M | SELL-OPTIONS | 0.00% | 526.18K | Apr 14 | View |
| Nov 04, 2015 | Wendell P Weeks | DIRECTOR | 0.00 | $44.99 | -$105.47K | SELL-OPTIONS | 0.00% | 200.00 | Nov 04 | View |
| Oct 30, 2015 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 0.00 | $44.89 | -$365.77K | SELL-OPTIONS | 0.00% | 441.88K | Oct 29 | View |
| Oct 29, 2015 | Adele D Ambrose | SR.V-P & CHIEF COMUNS OFFICER | 0.00 | $45.82 | -$691.17K | SELL-OPTIONS | 0.00% | 19.69K | Oct 29 | View |
| Oct 28, 2015 | Peter C Wendell | DIRECTOR | 0.00 | $44.64 | -$102.04K | SELL-OPTIONS | 0.00% | 1.00K | Oct 28 | View |
| Aug 04, 2015 | Clark Golestani | EVP & CHIEF INFO OFFICER | 3.71K | $49.46 | -$465.26K | SELL-OPTIONS | 21.32% | 21.11K | Jul 31 | View |
| May 11, 2015 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -10.63K | $60.44 | -$642.77K | SELL | -10.26% | 92.99K | May 11 | View |
| May 11, 2015 | Julie L Gerberding | EVP STRAT COMM, GL PUB POLICY | 7.84K | $48.14 | -$709.55K | SELL-OPTIONS | 32.47% | 31.99K | May 08 | View |
| May 05, 2015 | Bruce N Kuhlik | EXE V-P & GEN COUNSEL | 5.64K | $49.73 | -$1.54M | SELL-OPTIONS | 3.89% | 150.43K | May 02 - May 04 | View |
| Apr 29, 2015 | Michael J Holston | EVP, LEGAL | 40.00K | $52.12 | $297.92K | SELL-OPTIONS | ∞ | 40.00K | Apr 29 | View |
| Apr 29, 2015 | Bruce N Kuhlik | EXE V-P & GEN COUNSEL | 0.00 | $49.17 | -$3.34M | SELL-OPTIONS | 0.00% | 144.80K | Apr 29 | View |
| Feb 18, 2015 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 1.92K | $45.25 | -$77.47K | SELL-OPTIONS | 0.54% | 356.95K | Feb 18 | View |
| Feb 11, 2015 | Willie A Deese | EXE V-P & PRES. MMD | 0.00 | $49.50 | -$2.46M | SELL-OPTIONS | 0.00% | 106.92K | Feb 11 | View |
| Feb 09, 2015 | Peter C Wendell | DIRECTOR | 0.00 | $46.29 | -$124.65K | SELL-OPTIONS | 0.00% | 1.00K | Feb 09 | View |
| Jan 15, 2015 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | 0.00 | $51.83 | -$1.58M | SELL-OPTIONS | 0.00% | 70.79K | Jan 15 | View |
| Jan 09, 2015 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 4.03K | $48.33 | -$112.03K | SELL-OPTIONS | 1.15% | 355.03K | Jan 09 | View |
| Dec 10, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 3.03K | $47.10 | -$150.52K | SELL-OPTIONS | 0.87% | 350.97K | Dec 10 | View |
| Dec 08, 2014 | Bruce N Kuhlik | EXE V-P & GEN COUNSEL | 0.00 | $56.51 | -$549.00K | SELL-OPTIONS | 0.00% | 128.47K | Dec 08 | View |
| Nov 26, 2014 | Rochelle B Lazarus | DIRECTOR | 0.00 | $46.88 | -$254.95K | SELL-OPTIONS | 0.00% | 6.35K | Nov 26 | View |
| Nov 25, 2014 | Wendell P Weeks | DIRECTOR | 0.00 | $46.48 | -$126.51K | SELL-OPTIONS | 0.00% | 200.00 | Nov 24 | View |
| Nov 10, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 2.88K | $46.09 | -$139.51K | SELL-OPTIONS | 0.83% | 347.94K | Nov 10 | View |
| Oct 14, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 2.98K | $46.96 | -$150.76K | SELL-OPTIONS | 0.87% | 345.06K | Oct 10 | View |
| Sep 10, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 3.06K | $47.34 | -$153.32K | SELL-OPTIONS | 0.90% | 342.06K | Sep 10 | View |
| Aug 25, 2014 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -22.00K | $59.70 | -$1.31M | SELL | -23.71% | 70.79K | Aug 25 | View |
| Aug 12, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 2.82K | $45.60 | -$133.03K | SELL-OPTIONS | 0.84% | 339.00K | Aug 11 | View |
| Aug 05, 2014 | Adele D Ambrose | SR.V-P & CHIEF COMUNS OFFICER | -5.27K | $51.01 | -$561.90K | SELL | -27.10% | 14.17K | Aug 04 | View |
| Jul 10, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 2.89K | $46.11 | -$139.24K | SELL-OPTIONS | 0.84% | 344.96K | Jul 10 | View |
| Jul 08, 2014 | Mirian M. Graddick-Weir | EXE V-P, HR | 0.00 | $44.58 | -$5.25M | SELL-OPTIONS | 0.00% | 93.56K | Jul 07 | View |
| Jun 30, 2014 | Willie A Deese | EXE V-P & PRES. MMD | 0.00 | $43.05 | -$2.20M | SELL-OPTIONS | 0.00% | 106.90K | Jun 27 | View |
| Jun 11, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 2.89K | $46.13 | -$139.45K | SELL-OPTIONS | 0.85% | 342.07K | Jun 10 | View |
| May 14, 2014 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -10.53K | $55.91 | -$588.58K | SELL | -10.19% | 92.79K | May 14 | View |
| May 13, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 2.66K | $44.60 | -$121.79K | SELL-OPTIONS | 0.79% | 339.18K | May 09 | View |
| Apr 11, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 2.83K | $45.72 | -$134.80K | SELL-OPTIONS | 0.91% | 313.96K | Apr 10 | View |
| Apr 04, 2014 | Bruce N Kuhlik | EXE V-P & GEN COUNSEL | 0.00 | $48.17 | -$2.40M | SELL-OPTIONS | 0.00% | 121.84K | Apr 04 | View |
| Feb 14, 2014 | Clark Golestani | EVP & CHIEF INFO OFFICER | 385.00 | $51.86 | -$24.75K | SELL-OPTIONS | 4.47% | 8.99K | Feb 14 | View |
| Feb 14, 2014 | Bridgette P Heller | EXE.VP & PRES.CON.HLTH.CARE | 5.88K | $45.80 | -$595.71K | SELL-OPTIONS | 27.09% | 27.59K | Feb 13 | View |
| Feb 13, 2014 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | -4.04K | $51.64 | -$368.28K | SELL | -5.42% | 70.51K | Feb 11 | View |
| Feb 11, 2014 | Kenneth C Frazier | CHAIRMAN, PRESIDENT & CEO | 3.48K | $51.38 | -$92.88K | SELL-OPTIONS | 1.32% | 266.27K | Feb 11 | View |
| Feb 11, 2014 | John Canan | SR.V-P FINC-GLOBAL CONTROLLER | 0.00 | $51.97 | -$74.60K | SELL-OPTIONS | 0.00% | 14.04K | Feb 11 | View |
| Feb 11, 2014 | Willie A Deese | EXE V-P & PRES. MMD | -30.00K | $51.46 | -$1.77M | SELL | -21.94% | 106.72K | Feb 10 | View |
| Feb 11, 2014 | Peter C Wendell | DIRECTOR | 0.00 | $50.83 | -$36.04K | SELL-OPTIONS | 0.00% | 1.00K | Feb 10 | View |
| Feb 11, 2014 | Wendell P Weeks | DIRECTOR | 0.00 | $50.74 | -$35.13K | SELL-OPTIONS | 0.00% | 200.00 | Feb 10 | View |
| Nov 01, 2013 | Thomas R Cech | DIRECTOR | -500.00 | $45.13 | -$22.57K | SELL | -83.33% | 100.00 | Oct 31 | View |
| Aug 07, 2013 | Willie A Deese | EXE V-P & PRES. MMD | 0.00 | $42.46 | -$617.15K | SELL-OPTIONS | 0.00% | 106.70K | Aug 07 | View |
| May 16, 2013 | Adele D Ambrose | SR.V-P & CHIEF COMUNS OFFICER | -1.00K | $37.96 | -$624.63K | SELL | -6.75% | 13.81K | May 15 | View |
| May 15, 2013 | Bridgette P Heller | EXE.VP & PRES.CON.HLTH.CARE | -5.40K | $46.15 | -$249.40K | SELL | -19.93% | 21.71K | May 13 | View |
| May 08, 2013 | Bridgette P Heller | EXE.VP & PRES.CON.HLTH.CARE | 19.87K | $39.28 | -$1.14M | SELL-OPTIONS | 274.37% | 27.11K | May 07 | View |
| May 08, 2013 | Bruce N Kuhlik | EXE V-P & GEN COUNSEL | 15.96K | $38.96 | -$3.82M | SELL-OPTIONS | 17.27% | 108.39K | May 06 - May 07 | View |
| May 08, 2013 | Willie A Deese | EXE V-P & PRES. MMD | 8.04K | $38.99 | -$745.18K | SELL-OPTIONS | 8.15% | 106.70K | May 06 - May 07 | View |
| Nov 13, 2012 | Bruce N Kuhlik | EXE V-P & GEN COUNSEL | 0.00 | $36.52 | -$921.43K | SELL-OPTIONS | 0.00% | 77.81K | Nov 12 | View |
| Nov 06, 2012 | Peter S Kim | EXE V-P & PRES, MRL | 0.00 | $36.80 | -$7.31M | SELL-OPTIONS | 0.00% | 172.04K | Nov 05 | View |
| Nov 06, 2012 | Adam H Schechter | EVP & PRES-GLOBAL HUMAN HEALTH | 14.90K | $34.99 | -$830.82K | SELL-OPTIONS | 44.89% | 48.09K | Nov 05 | View |
| Aug 10, 2012 | Willie A Deese | EXE V-P & PRES. MMD | 0.00 | $37.12 | -$889.29K | SELL-OPTIONS | 0.00% | 89.05K | Aug 09 | View |
| Aug 02, 2012 | John Canan | SR.V-P FINC-GLOBAL CONTROLLER | -30.50K | $44.29 | -$1.35M | SELL | -78.82% | 8.20K | Aug 01 | View |
| May 10, 2012 | Richard S. Bowles III | EXE VP&CHIEF ETHICS & COMPLOFF | 0.00 | $29.58 | -$488.41K | SELL-OPTIONS | 0.00% | 77.29K | May 10 | View |
| Feb 21, 2012 | Richard S. Bowles III | EXE VP&CHIEF ETHICS & COMPLOFF | 0.00 | $34.36 | -$374.48K | SELL-OPTIONS | 0.00% | 77.25K | Feb 17 | View |
| Feb 09, 2012 | Willie A Deese | EXE V-P & PRES. MMD | 0.00 | $30.91 | -$633.84K | SELL-OPTIONS | 0.00% | 79.38K | Feb 08 | View |
| Nov 14, 2011 | Richard S. Bowles III | EXE VP&CHIEF ETHICS & COMPLOFF | 0.00 | $28.49 | -$444.60K | SELL-OPTIONS | 0.00% | 80.25K | Nov 11 | View |
| Aug 15, 2011 | Kenneth C Frazier | PRESIDENT & CEO | 32.00K | $31.78 | $1.02M | BUY | 19.57% | 195.51K | Aug 15 | View |
| Aug 15, 2011 | Peter N Kellogg | EXE V-P & CFO | 15.80K | $31.80 | $502.37K | BUY | 41.36% | 54.00K | Aug 12 | View |
| May 19, 2011 | Raul E Kohan | EXE V-P & PRES, ANIMAL HEALTH | 0.00 | $28.58 | -$1.10M | SELL-OPTIONS | 0.00% | 82.66K | May 18 | View |
| May 06, 2011 | Richard S. Bowles III | EXE V-P & CHIEF COMPL OFFICER | 0.00 | $29.62 | -$412.58K | SELL-OPTIONS | 0.00% | 80.17K | May 04 | View |
FAQ
Q
Is insider trading legal?
A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q
What are some examples of market manipulation?
A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
MRK Insider Trading News
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved